166 related articles for article (PubMed ID: 17237417)
21. Derepression of microRNA-mediated protein translation inhibition by apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members.
Huang J; Liang Z; Yang B; Tian H; Ma J; Zhang H
J Biol Chem; 2007 Nov; 282(46):33632-33640. PubMed ID: 17848567
[TBL] [Abstract][Full Text] [Related]
22. IFN-α induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells.
Mohanram V; Sköld AE; Bächle SM; Pathak SK; Spetz AL
J Immunol; 2013 Apr; 190(7):3346-53. PubMed ID: 23427247
[TBL] [Abstract][Full Text] [Related]
23. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA; Pathak VK
J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
[TBL] [Abstract][Full Text] [Related]
24. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation.
Kreisberg JF; Yonemoto W; Greene WC
J Exp Med; 2006 Apr; 203(4):865-70. PubMed ID: 16606671
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors.
He B; Qiao X; Klasse PJ; Chiu A; Chadburn A; Knowles DM; Moore JP; Cerutti A
J Immunol; 2006 Apr; 176(7):3931-41. PubMed ID: 16547227
[TBL] [Abstract][Full Text] [Related]
26. Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G.
Trapp S; Derby NR; Singer R; Shaw A; Williams VG; Turville SG; Bess JW; Lifson JD; Robbiani M
J Virol; 2009 Jan; 83(2):884-95. PubMed ID: 19004943
[TBL] [Abstract][Full Text] [Related]
27. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
[TBL] [Abstract][Full Text] [Related]
28. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
Peng G; Lei KJ; Jin W; Greenwell-Wild T; Wahl SM
J Exp Med; 2006 Jan; 203(1):41-6. PubMed ID: 16418394
[TBL] [Abstract][Full Text] [Related]
29. T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.
Thielen BK; Klein KC; Walker LW; Rieck M; Buckner JH; Tomblingson GW; Lingappa JR
PLoS Pathog; 2007 Sep; 3(9):1320-34. PubMed ID: 17892323
[TBL] [Abstract][Full Text] [Related]
30. Multifaceted antiviral actions of APOBEC3 cytidine deaminases.
Chiu YL; Greene WC
Trends Immunol; 2006 Jun; 27(6):291-7. PubMed ID: 16678488
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F.
Khatua AK; Taylor HE; Hildreth JE; Popik W
Virology; 2010 Apr; 400(1):68-75. PubMed ID: 20153011
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus.
Rose KM; Marin M; Kozak SL; Kabat D
J Biol Chem; 2004 Oct; 279(40):41744-9. PubMed ID: 15297452
[TBL] [Abstract][Full Text] [Related]
33. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
[TBL] [Abstract][Full Text] [Related]
34. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.
Mangeat B; Turelli P; Caron G; Friedli M; Perrin L; Trono D
Nature; 2003 Jul; 424(6944):99-103. PubMed ID: 12808466
[TBL] [Abstract][Full Text] [Related]
35. Expression of APOBEC3G in kidney cells.
Komohara Y; Suekane S; Noguchi M; Matsuoka K; Yamada A; Itoh K
Tissue Antigens; 2007 Jan; 69(1):95-8. PubMed ID: 17212712
[TBL] [Abstract][Full Text] [Related]
36. [Subcellular localization of APOBEC3G by confocal laser scanning microscope (CLSM)].
Yang YS; Li L; Li ZL; Zeng Y
Bing Du Xue Bao; 2007 Jan; 23(1):16-21. PubMed ID: 17886715
[TBL] [Abstract][Full Text] [Related]
37. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.
Koning FA; Newman EN; Kim EY; Kunstman KJ; Wolinsky SM; Malim MH
J Virol; 2009 Sep; 83(18):9474-85. PubMed ID: 19587057
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms.
McDyer JF; Dybul M; Goletz TJ; Kinter AL; Thomas EK; Berzofsky JA; Fauci AS; Seder RA
J Immunol; 1999 Mar; 162(6):3711-7. PubMed ID: 10092834
[TBL] [Abstract][Full Text] [Related]
39. Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene.
Muckenfuss H; Kaiser JK; Krebil E; Battenberg M; Schwer C; Cichutek K; Münk C; Flory E
Nucleic Acids Res; 2007; 35(11):3784-96. PubMed ID: 17517765
[TBL] [Abstract][Full Text] [Related]
40. Protecting APOBEC3G: a potential new target for HIV drug discovery.
Stopak K; Greene WC
Curr Opin Investig Drugs; 2005 Feb; 6(2):141-7. PubMed ID: 15751736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
